En esta página
01MBOT precio
02Instantánea
03Gráfico
04Divisiones de acciones
06Rendimiento
07Valoración y ratios
14Ganancias
15Fundamentales Completos
16Estados Financieros
17Propietarios institucionales (13F)
18Activistas y propietarios del %+ 5
19Informantes de la empresa
20Propiedad de ETFs
21Consenso
22Pares
26Mis Métricas
MBOT Microbot Medical Inc. - Common Stock
NASDAQ · Health Care · Ver en SEC EDGAR ↗ cerrar Oct 2, 2026 10-K/10-Q Ago 11, 2026
$1,16
· % del rango de 52 semanas
· por encima del mínimo
· a alto
$1,14mínimo 52 semanas
$3,46máximo 52 semanas
Capitalización Bursátil (MRQ)
$78M
P/E
-4.0
BPA
$-0.29
tus insignias
Rango 52S
$1–$3
Calificación del Analista
BUY
Precio Objetivo
$6
P/E
-4.0
ROE
-24.4%
Margen de Beneficio Neto
·
Tu barra de insignias está vacía — fija una métrica en cualquier lugar de esta página.
MBOT Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$1.16
Capitalización Bursátil (MRQ)
$78M
P/E
-4.0
BPA
$-0.29
ROE
-24.4%
Rango 52S
$1–$3
MBOT Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
rango
barras
La granularidad de las barras se adapta al período seleccionado; pase el ratón sobre el gráfico para ver la apertura/máximo/mínimo/cierre de una barra.
Divisiones de acciones
| Fecha ex-dividendo | División | Tipo |
|---|---|---|
| 5 de septiembre de 2018 | 1-for-15 | Inversa |
| 29 de noviembre de 2016 | 1-for-9 | Inversa |
| 9 de mayo de 2016 | 1-for-12 | Inversa |
| 6 de julio de 2011 | 1-for-10 | Inversa |
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
BPA$-0.292022-12-31 → 2025-12-31
Flujo de caja libre$-13M2016-12-31 → 2025-12-31
Margen neto·2018-12-31 → 2018-12-31
Valoración y ratios
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
| Métrica | Tendencia a 5 años | MBOT | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| P/E | -4.0promedio 5A ≈-2.9 | ≈-2.9 | · | · | |
| P/S | 681.9promedio 5A ≈441.7 | ≈441.7 | 12.2 | Sobrevalorado | |
| P/C (MRQ) | 1.1promedio 5A ≈3.8 | ≈3.8 | 1.9 | Valor razonable | |
| Precio / FCF (TTM) | -4.3promedio 5A ≈-4.5 | ≈-4.5 | · | · | |
| Precio / Flujo de Caja (TTM) | -4.4promedio 5A ≈-4.6 | ≈-4.6 | · | · | |
| Price / Tangible Book (Precio / Valor Contable Tangible) | 1.0promedio 5A ≈3.8 | ≈3.8 | · | · |
La mediana de empresas comparables se calcula sobre una base estandarizada por métrica y puede no coincidir siempre con la base TTM/MRQ que se muestra para esta acción.
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
| Métrica | Tendencia a 5 años | MBOT | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| ROA | -30.0%promedio 5A ≈-92.5% | ≈-92.5% | -43.4% | De primer nivel | |
| ROE | -24.4%promedio 5A ≈-158.6% | ≈-158.6% | -41.2% | De primer nivel |
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
| Métrica | Tendencia a 5 años | MBOT | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Ratio corriente (MRQ) | 18.6promedio 5A ≈8.0 | ≈8.0 | 3.8 | Liquidez sólida | |
| Ratio Rápido (MRQ) | 17.4promedio 5A ≈7.7 | ≈7.7 | 3.2 | Liquidez sólida |
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
Aún no hay datos para este grupo de ratios
Aún no hay datos fundamentales para este ticker.
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
Aún no hay datos para este grupo de ratios
Aún no hay datos fundamentales para este ticker.
valor · ≈ promedio 5A · mediana sectorial · veredicto relativo a la mediana
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
Sorpresa Media
7.8%
Próximo informe
Nov 10, 2026
| Período | Informe | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|---|
| 30 de junio de 2026 | Ago 10, 2026 | $-0.08 | $-0.08 | -2.3% |
| 31 de marzo de 2026 | May 12, 2026 | $-0.05 | $-0.08 | 36.1% |
| 31 de diciembre de 2025 | $-0.04 | $-0.06 | 34.6% | |
| 30 de septiembre de 2025 | $-0.07 | $-0.06 | -14.4% | |
| 30 de junio de 2025 | $-0.10 | $-0.08 | -22.5% | |
| 31 de marzo de 2025 | $-0.09 | $-0.13 | 32.1% | |
| 31 de diciembre de 2024 | $-0.20 | $-0.18 | -8.9% |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | · | · | · | · | · | · | $116.9K | · | |
| R&D Expense | $6M | $7M | $6M | $8M | $6M | $3M | $3M | $3M | $1M | $-901.0K | $-823.0K | $22M | |
| SG&A Expense | $8M | $5M | $4M | $6M | $5M | $6M | $4M | $5M | $4M | $-9M | $-92.0K | $10M | |
| Operating Expenses | · | · | · | $5M | $4M | · | · | · | · | · | $37M | $32M | |
| Operating Income | $-15M | $-12M | $-10M | $-13M | $-11M | $-9M | $-7M | $-7M | $5M | $-10M | $915.0K | $-31M | |
| Interest Expense | · | · | · | · | · | · | · | · | $237.0K | $333.0K | $6.0K | $1M | |
| Interest Income | · | · | · | · | · | · | · | · | · | · | $7.5K | $8.5K | |
| Other Non-op | · | · | · | $-5.0K | · | · | · | · | · | · | $129.8K | $-45.8K | |
| Pretax Income | · | · | · | · | · | · | · | · | · | · | $36M | $33M | |
| Income Tax | · | · | · | · | · | · | $0 | · | · | · | · | · | |
| Net Income | $-13M | $-11M | $-11M | $-13M | $-11M | $-9M | $-7M | $-7M | $-8M | $-10M | $-921.0K | $-33M | |
| EPS (Basic) | $-0.29 | $-0.73 | $-1.05 | $-1.81 | $-1.59 | · | · | · | · | · | · | · | |
| EPS (Diluted) | $-0.29 | $-0.73 | $-1.05 | $-1.81 | · | · | · | · | · | · | · | · | |
| Shares (Basic) | 45,790,362 | 15,644,511 | 10,199,984 | 7,260,344 | 7,108,133 | · | · | · | · | · | · | · | |
| Shares (Diluted) | 45,790,362 | 15,644,511 | 10,199,984 | 7,260,344 | · | · | · | · | · | · | · | · | |
| EBITDA | $-15M | $-12M | $-10M | $-13M | $-11M | · | · | $7M | $-5M | $10M | $-36M | $-30M |
Balance general
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $4M | $3M | $2M | $2M | $13M | $20M | $29M | $5M | $11M | $3M | $437.0K | $791.0K | |
| Short-term Investments | $75M | $2M | $4M | $6M | $2M | $5M | $3M | · | · | · | · | · | |
| Receivables | · | · | · | · | · | · | · | · | · | · | · | $159.5K | |
| Inventory | $584.0K | · | · | · | · | · | · | · | · | · | · | · | |
| Prepaid Expense | $644.0K | $300.0K | $152.0K | $532.0K | $300.0K | $521.0K | $286.0K | $568.0K | $81.0K | $191.0K | $25.0K | $1M | |
| Other Current Assets | · | · | $1M | · | $300.0K | $521.0K | $286.0K | $568.0K | $116.0K | $606.0K | · | $64.9K | |
| Current Assets | $80M | $6M | $8M | $9M | $16M | $25M | $36M | $6M | $11M | $3M | $491.0K | $27M | |
| PP&E (Net) | $93.0K | $80.0K | $146.0K | $221.0K | $244.0K | $251.0K | $228.0K | $259.0K | $90.0K | $53.0K | $38.0K | $5M | |
| PP&E (Gross) | $724.0K | $664.0K | $639.0K | $608.0K | $533.0K | $464.0K | $373.0K | $391.0K | $168.0K | $110.0K | $92.0K | $16M | |
| Accum. Depreciation | $631.0K | $584.0K | $493.0K | $387.0K | $289.0K | $213.0K | $145.0K | $132.0K | $78.0K | $57.0K | $54.0K | $10M | |
| Intangibles | · | · | · | · | · | · | · | · | · | · | $45.8K | $356.9K | |
| Other Non-current Assets | · | · | · | · | · | · | · | · | · | · | $742.7K | $373.7K | |
| Total Assets | $82M | $6M | $8M | $10M | $17M | $26M | $37M | $6M | $11M | $3M | $529.0K | $32M | |
| Accounts Payable | $511.0K | $165.0K | $357.0K | $116.0K | $279.0K | $275.0K | $284.0K | $630.0K | $78.0K | $512.0K | $25.0K | $2M | |
| Accrued Liabilities | $3M | $2M | $1M | $2M | $1M | $883.0K | $795.0K | $755.0K | $450.0K | $271.0K | $149.0K | $5M | |
| Current Liabilities | $3M | $2M | $4M | $2M | $2M | $1M | $5M | $5M | $528.0K | $783.0K | $174.0K | $11M | |
| Capital Leases | $569.0K | $41.0K | $40.0K | $179.0K | $402.0K | $626.0K | $760.0K | · | · | · | $15.9K | $9.2K | |
| Other Non-current Liabilities | · | · | · | · | · | · | · | · | · | · | $369.4K | $1M | |
| Total Liabilities | $4M | $3M | $4M | $2M | $2M | $2M | $6M | $5M | $556.0K | $1M | $419.0K | $27M | |
| Common Stock | $672.0K | $195.0K | $118.0K | $80.0K | $72.0K | $72.0K | $72.0K | $31.0K | $27.0K | $266.0K | $132.0K | $687.3K | |
| Paid-in Capital | · | · | · | · | · | · | · | $33M | $31M | $14M | $3M | · | |
| Retained Earnings | $-104M | $-91M | $-80M | $-69M | $-56M | $-44M | $-35M | $-28M | $-21M | $-13M | $-3M | $-420M | |
| Treasury Stock | · | · | · | · | · | · | $3M | $3M | · | · | · | · | |
| AOCI | · | · | · | · | · | · | · | · | · | · | $47.4K | $65.4K | |
| Stockholders' Equity | $78M | $4M | $5M | $7M | $14M | $24M | $32M | $1M | $10M | $2M | $-64.0K | $857.0K | |
| Liabilities + Equity | $82M | $6M | $8M | $10M | $17M | $26M | $37M | $6M | $11M | $3M | $529.0K | $32M | |
| Shares Outstanding | 67,158,044 | 19,399,513 | 11,707,317 | 7,890,628 | 7,108,133 | 7,108,133 | 7,185,628 | 3,012,343 | 2,013,193 | 15,848,136 | 13,182,660 | 68,729,774 |
Flujo de Efectivo
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $47.0K | $91.0K | $106.0K | $102.0K | $76.0K | $68.0K | $84.0K | $54.0K | · | · | $1M | $1M | |
| Stock-based Comp | $1M | $1M | $1M | $2M | $1M | $2M | $1M | $1M | $479.0K | $676.0K | · | $2M | |
| Amort. of Intangibles | · | · | · | · | · | · | · | · | · | · | $72.0K | $299.0K | |
| Other Non-cash | $-1M | $1M | $707.0K | $-235.0K | $497.0K | · | · | · | · | · | $365.5K | $2M | |
| Operating Cash Flow | $-13M | $-9M | $-9M | $-12M | $-9M | $-7M | $-6M | $-5M | $-5M | $-786.0K | $-765.0K | $-27M | |
| CapEx | $60.0K | $25.0K | $33.0K | $84.0K | $69.0K | $91.0K | $216.0K | $223.0K | $58.0K | $25.0K | $2.0K | $903.9K | |
| Investing Cash Flow | $-72M | $2M | $2M | $-4M | $3M | $-3M | $-2M | $-223.0K | $-58.0K | $-25.0K | $-2.0K | $-425.6K | |
| Debt Issued | · | · | · | · | · | · | · | · | · | · | $5M | $5M | |
| Net Debt Issued | · | · | · | · | · | · | · | · | · | · | $5M | $5M | |
| Stock Issued | · | · | · | · | · | · | $37M | · | $13M | · | $26M | $19M | |
| Net Stock Activity | · | · | · | · | · | · | · | · | $13M | · | $26M | $19M | |
| Financing Cash Flow | $86M | $8M | $7M | $4M | · | $-3M | $37M | $-18.0K | $13M | $3M | $413.0K | $22M | |
| Net Change in Cash | $810.0K | $646.0K | $-2.0K | $-11M | $-6M | $-13M | $28M | $-6M | $8M | $2M | $-354.0K | $-6M | |
| Free Cash Flow | $-13M | $-9M | $-9M | $-12M | $-9M | · | · | $-6M | $-5M | $-811.0K | $-32M | $-28M |
Rentabilidad
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | · | · | · | 362200.0% | · | · | -31415.3% | · | |
| Net Margin | · | · | · | · | · | · | · | -362000.0% | · | · | -31154.0% | · | |
| Pretax Margin | · | · | · | · | · | · | · | · | · | · | 31154.0% | · | |
| EBITDA Margin | · | · | · | · | · | · | · | 362200.0% | · | · | -30452.3% | · | |
| ROA | -30.0% | -159.4% | -120.2% | -100.1% | -52.6% | · | · | -84.6% | -105.5% | -495.9% | -135.8% | -88.5% | |
| ROE | -24.4% | -311.9% | -181.1% | -205.4% | -70.2% | · | · | -195.9% | -130.2% | -1184.2% | -13931.0% | -314.4% |
Liquidez y Solvencia
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 23.3 | 2.4 | 2.1 | 4.3 | 8.0 | · | · | 1.2 | 20.7 | 4.2 | 1.5 | 2.3 | |
| Quick Ratio | 23.0 | 2.2 | 1.7 | 4.0 | 7.8 | · | · | 1.1 | 20.4 | 3.5 | 1.2 | 2.2 | |
| Interest Coverage | · | · | · | · | · | · | · | · | -22.2 | 28.9 | -72.5 | -23.9 |
Eficiencia
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | · | · | 0.0 | · | · | 0.0 | · |
Por Acción
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.15 | $0.18 | $0.38 | $0.92 | $2.02 | · | · | $0.44 | $0.33 | $0.11 | $-0.00 | $0.09 | |
| Cash Flow / Share | $-0.28 | $-0.56 | $-0.84 | · | · | · | · | · | · | · | · | · | |
| Cash / Share | $0.06 | $0.16 | $0.21 | $0.31 | $1.90 | · | · | $1.74 | $0.36 | $0.17 | $0.11 | $0.36 | |
| EPS (TTM) | $-0.29 | $-0.73 | $-1.05 | $-1.81 | · | · | · | · | · | · | · | · |
Valoración (TTM)
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $114.2K | $114.2K | $114.2K | $114.2K | $114.2K | $114.2K | $114.2K | $114.2K | $114.2K | $114.2K | $116.9K | $1M | |
| Net Income TTM | $-13M | $-11M | $-11M | $-13M | $-11M | $-9M | $-7M | $-7M | $-8M | $-10M | $-921.0K | $-33M | |
| Market Cap | $134M | $22M | $19M | $24M | $53M | · | · | $5M | $457M | $1.45B | $75.76B | $104.66B | |
| P/E | -6.9 | -1.5 | -1.6 | -1.7 | · | · | · | · | · | · | · | · | |
| P/S | 1175.8 | 190.2 | 168.1 | 207.9 | 466.7 | · | · | 45.4 | 4001.9 | 12693.8 | 648158.8 | 103420.7 | |
| P/B | 1.7 | 6.2 | 4.3 | 3.3 | 3.7 | · | · | 3.9 | 45.9 | 855.0 | -226687.8 | 17827.6 | |
| P / Tangible Book | 1.7 | 6.2 | 4.3 | 3.3 | 3.7 | 2.0 | · | · | · | · | · | · | |
| P / Cash Flow | -10.3 | -2.5 | -2.3 | -2.1 | -5.7 | · | · | -1.0 | -94.1 | -1844.9 | -2469.5 | -3826.4 | |
| P / FCF | -10.2 | -2.5 | -2.2 | -2.0 | -5.7 | · | · | -0.9 | -93.0 | -1788.0 | -2387.4 | -3704.0 | |
| Earnings Yield | -14.5% | -65.2% | -64.0% | -60.1% | · | · | · | · | · | · | · | · |
Estado de resultados
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $241.0K | $105.0K | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Cost of Revenue | $884.0K | $103.0K | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Gross Profit | $-643.0K | $2.0K | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| R&D Expense | $2M | $1M | $2M | $1M | $2M | $1M | $2M | $2M | $1M | $1M | $1M | $2M | $1M | $2M | $2M | $2M | |
| SG&A Expense | $4M | $3M | $3M | $3M | $2M | $2M | $1M | $1M | $1M | $1M | $938.0K | $932.0K | $959.0K | $1M | $1M | $2M | |
| Operating Income | $-6M | $-4M | $-4M | $-4M | $-4M | $-3M | $-3M | $-3M | $-3M | $-2M | $-2M | $-3M | $-2M | $-3M | $-3M | $-3M | |
| Other Non-op | · | · | · | · | · | $316.0K | · | · | · | · | · | · | · | · | · | · | |
| Net Income | $-6M | $-4M | $-3M | $-4M | $-4M | $-3M | $-3M | $-3M | $-2M | $-2M | $-3M | $-2M | $-2M | $-3M | $-3M | $-3M | |
| EPS (Basic) | $-0.08 | $-0.05 | $-0.04 | $-0.07 | $-0.10 | $-0.08 | $-0.19 | $-0.20 | $-0.17 | $-0.17 | $-0.23 | $-0.21 | $-0.25 | $-0.36 | $-0.38 | $-0.49 | |
| EPS (Diluted) | $-0.08 | $-0.05 | $-0.04 | $-0.07 | $-0.10 | $-0.08 | $-0.19 | $-0.20 | $-0.17 | $-0.17 | $-0.23 | $-0.21 | $-0.25 | $-0.36 | $-0.38 | $-0.49 | |
| Shares (Basic) | 67,163,613 | 67,158,044 | · | 48,095,384 | 36,488,014 | 31,085,606 | · | 16,471,419 | 14,846,584 | 14,055,973 | · | 11,707,317 | 9,198,806 | 8,013,295 | · | 7,108,133 | |
| Shares (Diluted) | 67,163,613 | 67,158,044 | · | 48,095,384 | 36,488,014 | 31,085,606 | · | 16,471,419 | 14,846,584 | 14,055,973 | · | 11,707,317 | 9,198,806 | 8,013,295 | · | 7,108,133 | |
| EBITDA | $-6M | $-4M | · | $-4M | $-4M | $-3M | · | $-3M | $-3M | $-2M | · | $-3M | $-2M | $-3M | · | $-3M |
Balance general
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $3M | $4M | $4M | $7M | $4M | $3M | $3M | $479.0K | $2M | $1M | $2M | $1M | $6M | $2M | $2M | $4M | |
| Short-term Investments | $64M | $69M | $75M | $73M | $29M | $27M | $2M | $4M | $4M | $5M | $4M | $7M | $4M | $3M | $6M | $2M | |
| Receivables | $176.0K | $105.0K | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Inventory | $3M | $2M | $584.0K | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Prepaid Expense | $709.0K | $660.0K | $644.0K | $573.0K | $164.0K | $218.0K | $300.0K | $609.0K | $628.0K | $603.0K | $152.0K | $208.0K | $371.0K | $475.0K | $532.0K | $193.0K | |
| Other Current Assets | · | · | · | · | · | · | · | · | · | · | $1M | · | · | · | · | · | |
| Current Assets | $72M | $77M | $80M | $81M | $33M | $31M | $6M | $5M | $7M | $7M | $8M | $8M | $10M | $6M | $9M | $7M | |
| PP&E (Net) | $316.0K | $188.0K | $93.0K | $78.0K | $75.0K | $78.0K | $80.0K | $99.0K | $122.0K | $132.0K | $146.0K | $184.0K | $180.0K | $196.0K | $221.0K | $258.0K | |
| PP&E (Gross) | · | · | $724.0K | · | · | · | $664.0K | · | · | · | $639.0K | · | · | · | $608.0K | · | |
| Accum. Depreciation | · | · | $631.0K | · | · | · | $584.0K | · | · | · | $493.0K | · | · | · | $387.0K | · | |
| Total Assets | $73M | $78M | $82M | $82M | $33M | $31M | $6M | $5M | $7M | $7M | $8M | $9M | $11M | $6M | $10M | $7M | |
| Accounts Payable | $871.0K | $1M | $511.0K | $509.0K | $503.0K | $186.0K | $165.0K | $246.0K | $178.0K | $96.0K | · | $238.0K | $240.0K | $224.0K | · | $287.0K | |
| Accrued Liabilities | $3M | $2M | $3M | $2M | $2M | $2M | $2M | $1M | $1M | $896.0K | $1M | $1M | $859.0K | $743.0K | $2M | $1M | |
| Current Liabilities | $4M | $3M | $3M | $3M | $3M | $2M | $2M | $1M | $1M | $1M | $4M | $1M | $1M | $1M | $2M | $2M | |
| Capital Leases | $550.0K | $574.0K | $569.0K | $602.0K | $47.0K | $48.0K | $41.0K | $29.0K | $38.0K | $17.0K | $40.0K | $39.0K | $92.0K | $127.0K | $179.0K | $226.0K | |
| Total Liabilities | $4M | $4M | $4M | $4M | $3M | $2M | $3M | $1M | $1M | $1M | $4M | $2M | $1M | $1M | $2M | $2M | |
| Common Stock | $672.0K | $672.0K | $672.0K | $659.0K | $380.0K | $348.0K | $195.0K | $168.0K | $161.0K | $145.0K | $118.0K | $118.0K | $118.0K | $83.0K | $80.0K | $72.0K | |
| Retained Earnings | $-113M | $-108M | $-104M | $-101M | $-97M | $-94M | $-91M | $-88M | $-84M | $-82M | $-80M | $-76M | $-74M | $-72M | $-69M | $-66M | |
| Stockholders' Equity | $69M | $74M | $78M | $78M | $30M | $29M | $4M | $4M | $6M | $6M | $5M | $7M | $9M | $5M | $7M | $6M | |
| Liabilities + Equity | $73M | $78M | $82M | $82M | $33M | $31M | $6M | $5M | $7M | $7M | $8M | $9M | $11M | $6M | $10M | $7M | |
| Shares Outstanding | 67,164,801 | 67,158,044 | 67,158,044 | 65,833,556 | 37,958,316 | 34,744,476 | 19,399,513 | 16,651,433 | 15,965,633 | 14,398,964 | 11,707,317 | 11,707,317 | 11,707,317 | 8,130,628 | 7,890,628 | 7,108,133 |
Flujo de Efectivo
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $15.0K | $12.0K | $10.0K | $10.0K | $12.0K | $15.0K | $26.0K | $23.0K | $14.0K | $28.0K | $35.0K | $20.0K | $26.0K | $25.0K | $33.0K | $25.0K | |
| Stock-based Comp | $433.0K | $222.0K | $236.0K | $328.0K | $237.0K | $256.0K | $282.0K | $283.0K | $331.0K | $453.0K | $297.0K | $336.0K | $349.0K | $412.0K | $430.0K | $461.0K | |
| Other Non-cash | · | $-2M | · | · | · | $-544.0K | · | · | · | $-530.0K | · | · | · | $-787.0K | · | · | |
| Operating Cash Flow | $-5M | $-5M | $-4M | $-4M | $-3M | $-3M | $-2M | $-3M | $-2M | $-2M | $-2M | $-2M | $-2M | $-3M | $-2M | $-3M | |
| CapEx | $142.0K | $108.0K | $25.0K | $13.0K | $9.0K | $13.0K | $7.0K | $0 | $4.0K | $14.0K | $-5.0K | $28.0K | · | · | $1.0K | $5.0K | |
| Investing Cash Flow | $4M | $5M | $-2M | $-45M | $-1M | $-25M | $1M | $140.0K | $1M | $-1M | $3M | $-3M | $-1M | $3M | $-4M | $-5.0K | |
| Financing Cash Flow | · | · | $3M | $51M | $5M | $28M | $3M | $633.0K | $2M | $2M | $0 | $-161.0K | · | · | · | · | |
| Net Change in Cash | $-502.0K | $-56.0K | $-3M | $3M | $870.0K | $102.0K | $3M | $-2M | $1M | $-1M | $1M | $-4M | $4M | $-320.0K | $-2M | $-3M | |
| Free Cash Flow | · | $-5M | · | · | · | $-3M | · | · | · | $-2M | · | · | · | · | · | · |
Rentabilidad
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | -266.8% | 1.9% | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Operating Margin | -2567.6% | -4114.3% | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Net Margin | -2334.9% | -3496.2% | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| EBITDA Margin | -2567.6% | -4102.9% | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| ROA | -10.6% | -6.7% | · | -8.2% | -17.3% | -13.6% | · | -45.6% | -26.9% | -34.9% | · | -30.0% | -21.3% | -28.7% | · | -25.6% | |
| ROE | -11.3% | -7.1% | · | -8.7% | -19.2% | -14.8% | · | -57.6% | -31.8% | -43.0% | · | -38.0% | -25.4% | -34.6% | · | -29.6% |
Liquidez y Solvencia
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 18.6 | 22.6 | · | 27.5 | 12.1 | 16.2 | · | 3.6 | 5.3 | 5.9 | · | 5.6 | 7.8 | 4.5 | · | 4.0 | |
| Quick Ratio | 17.4 | 21.4 | · | 27.3 | 12.0 | 16.1 | · | 3.2 | 4.8 | 5.4 | · | 5.5 | 7.5 | 4.1 | · | 3.8 |
Eficiencia
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Inventory Turnover | 0.6 | 0.1 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Receivables Turnover | 2.7 | 1.7 | · | · | · | · | · | · | · | · | · | · | · | · | · | · |
Por Acción
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.03 | $1.10 | · | $1.19 | $0.80 | $0.83 | · | $0.23 | $0.38 | $0.43 | · | $0.63 | $0.81 | $0.60 | · | $0.78 | |
| Revenue / Share | $0.00 | $0.00 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Cash Flow / Share | · | $-0.08 | · | · | · | $-0.09 | · | · | · | $-0.17 | · | · | · | · | · | · | |
| Cash / Share | $0.05 | $0.05 | · | $0.10 | $0.11 | $0.09 | · | $0.03 | $0.15 | $0.08 | · | $0.11 | $0.49 | $0.26 | · | $0.61 | |
| EPS (TTM) | $-0.24 | $-0.26 | · | $-0.44 | $-0.57 | $-0.64 | · | $-0.77 | $-0.78 | $-0.86 | · | $-1.20 | $-1.48 | $-1.72 | · | · |
Valoración (TTM)
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | · | · | $114.2K | $114.2K | $114.2K | · | $114.2K | $114.2K | $114.2K | · | $114.2K | $114.2K | $114.2K | · | $114.2K | |
| Net Income TTM | $-16M | $-14M | · | $-13M | $-13M | $-12M | · | $-11M | $-10M | $-10M | · | $-11M | $-12M | $-13M | · | $-14M | |
| Market Cap | $131M | $162M | · | $201M | $96M | $52M | · | $15M | $16M | $18M | · | $16M | $32M | $17M | · | $34M | |
| P/E | -8.1 | -9.3 | · | -6.9 | -4.4 | -2.4 | · | -1.2 | -1.3 | -1.4 | · | -1.2 | -1.8 | -1.2 | · | · | |
| P/S | · | · | · | 1757.7 | 837.3 | 459.3 | · | 129.7 | 142.6 | 155.0 | · | 142.5 | 278.8 | 148.0 | · | 297.4 | |
| P/B | 1.9 | 2.2 | · | 2.6 | 3.2 | 1.8 | · | 3.9 | 2.7 | 2.9 | · | 2.2 | 3.4 | 3.5 | · | 6.1 | |
| P / Tangible Book | 1.9 | 2.2 | · | 2.6 | 3.2 | 1.8 | · | 3.9 | 2.7 | 2.9 | · | 2.2 | 3.4 | 3.5 | · | 6.1 | |
| P / Cash Flow | · | -32.0 | · | · | · | -18.3 | · | · | · | -7.3 | · | · | · | -5.3 | · | · | |
| Earnings Yield | -12.3% | -10.8% | · | -14.4% | -22.6% | -42.4% | · | -86.5% | -76.5% | -69.9% | · | -86.3% | -54.4% | -82.7% | · | · |
Período más reciente a la izquierda · valores nulos mostrados como ·
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Beneficio neto | $-13M | $-11M | $-11M | $-13M | $-11M |
| EPS Diluido | $-0.29 | $-0.73 | $-1.05 | $-1.81 | · |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ratio corriente | 23.3 | 2.4 | 2.1 | 4.3 | 8.0 |
| Ratio Rápido | 23.0 | 2.2 | 1.7 | 4.0 | 7.8 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Flujo de caja libre | $-13M | $-9M | $-9M | $-12M | $-9M |
Propietarios institucionales (13F) 83 declarantes · $34.4M total · A fecha de 30 de junio de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
Tenedores
83
Valor en tenencia
$34.4M
Nuevas posiciones
11
Posiciones cerradas
17
Actividad institucional — Q2 2026 vs trimestre anterior
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 11 (-13 vs trimestre anterior) | 17 (+6 vs trimestre anterior) | 24 (-3 vs trimestre anterior) | 16 (+1 vs trimestre anterior) | -2.5M |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| VANGUARD GROUP INC | $6 659 442 | 3 329 721 | 19,36% | Acciones |
| VANGUARD CAPITAL MANAGEMENT LLC | $5 668 280 | 2 906 810 | 16,48% | Acciones |
| CIBC Private Wealth Group LLC | $4 434 700 | 1 454 000 | 12,90% | Acciones |
| Mitsubishi UFJ Asset Management Co., Ltd. | $2 473 483 | 1 268 453 | 7,19% | Acciones |
| BlackRock, Inc. | $1 759 701 | 902 411 | 5,12% | Acciones |
| GEODE CAPITAL MANAGEMENT, LLC | $1 631 472 | 836 271 | 4,74% | Acciones |
| UBS Group AG | $1 573 352 | 806 847 | 4,58% | Acciones |
| DNB Asset Management AS | $1 321 121 | 677 498 | 3,84% | Acciones |
| STIFEL FINANCIAL CORP | $1 150 367 | 589 924 | 3,35% | Acciones |
| MARSHALL WACE, LLP | $1 056 831 | 541 963 | 3,07% | Acciones |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1 025 363 | 525 827 | 2,98% | Acciones |
| VANGUARD FIDUCIARY TRUST CO | $840 514 | 431 033 | 2,44% | Acciones |
| STATE STREET CORP | $591 960 | 303 569 | 1,72% | Acciones |
| AlphaCentric Advisors LLC | $487 500 | 250 000 | 1,42% | Acciones |
| WOLVERINE TRADING, LLC | $335 680 | 104 900 | 0,98% | Opción de compra |
| NORTHERN TRUST CORP | $287 684 | 147 530 | 0,84% | Acciones |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $245 115 | 125 700 | 0,71% | Opción de venta |
| GROUP ONE TRADING LLC | $207 537 | 106 429 | 0,60% | Acciones |
| JANE STREET GROUP, LLC | $206 961 | 106 134 | 0,60% | Acciones |
| AMERICAN CENTURY COMPANIES INC | $181 962 | 93 314 | 0,53% | Acciones |
| CITADEL ADVISORS LLC | $180 375 | 92 500 | 0,52% | Opción de compra |
| MILLENNIUM MANAGEMENT LLC | $168 289 | 86 302 | 0,49% | Acciones |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $166 335 | 85 300 | 0,48% | Opción de compra |
| Cubist Systematic Strategies, LLC | $118 904 | 38 985 | 0,35% | Acciones |
| Invesco Ltd. | $101 792 | 52 201 | 0,30% | Acciones |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $97 500 | 50 000 | 0,28% | Acciones |
| Vontobel Holding Ltd. | $93 772 | 48 088 | 0,27% | Acciones |
| ENVESTNET ASSET MANAGEMENT INC | $92 481 | 47 426 | 0,27% | Acciones |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $86 385 | 44 300 | 0,25% | Acciones |
| Cetera Investment Advisers | $85 433 | 43 812 | 0,25% | Acciones |
| WOLVERINE TRADING, LLC | $75 520 | 23 600 | 0,22% | Opción de venta |
| LAZARI CAPITAL MANAGEMENT, INC. | $71 370 | 36 600 | 0,21% | Acciones |
| Hilltop Holdings Inc. | $69 740 | 35 764 | 0,20% | Acciones |
| XTX Topco Ltd | $67 101 | 34 411 | 0,20% | Acciones |
| SCOTIA CAPITAL INC. | $64 108 | 32 876 | 0,19% | Acciones |
| Beacon Capital Management, LLC | $62 400 | 32 000 | 0,18% | Acciones |
| CITADEL ADVISORS LLC | $62 400 | 32 000 | 0,18% | Opción de venta |
| SIMPLEX TRADING, LLC | $58 868 | 30 189 | 0,17% | Acciones |
| LPL Financial LLC | $57 798 | 29 640 | 0,17% | Acciones |
| Private Advisor Group, LLC | $44 560 | 22 851 | 0,13% | Acciones |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | $42 107 | 22 279 | 0,12% | Acciones |
| Squarepoint Ops LLC | $39 558 | 20 286 | 0,12% | Acciones |
| Vanguard Global Advisers, LLC | $38 943 | 19 971 | 0,11% | Acciones |
| OSAIC HOLDINGS, INC. | $32 375 | 16 605 | 0,09% | Acciones |
| Caitong International Asset Management Co., Ltd | $26 411 | 13 544 | 0,08% | Acciones |
| Qube Research & Technologies Ltd | $26 313 | 13 494 | 0,08% | Acciones |
| Focus Partners Wealth | $25 321 | 12 985 | 0,07% | Acciones |
| MORGAN STANLEY | $23 504 | 12 053 | 0,07% | Acciones |
| Tower Research Capital LLC (TRC) | $22 324 | 11 448 | 0,06% | Acciones |
| KESTRA PRIVATE WEALTH SERVICES, LLC | $21 450 | 11 000 | 0,06% | Acciones |
Activistas y propietarios del %+ 5 6 tenencias
Inversores que presentaron el Anexo 13D de la SEC — propiedad beneficiosa superior al % 5 con la intención de influir en el emisor (participaciones activistas, campañas de la junta directiva, M&A). Cada fila muestra el estado conocido más reciente de la posición de ese declarante.
| Declarante | Presentado | Participación | Estado | Propósito | Presentación |
|---|---|---|---|---|---|
| Harel Gadot, MEDX Ventures Group LLC ×4 presentaciones | 2 de enero de 2020 | · | Presentación inicial | · | SEC |
| Yoseph Bornstein, LSA- Life Science Accelerator Ltd. ×4 presentaciones | 26 de octubre de 2017 | · | Presentación inicial | · | SEC |
| Moshe Shoham ×4 presentaciones | 18 de octubre de 2017 | · | Presentación inicial | · | SEC |
| Avram Berkson, Sandra Berkson, Saber Holding GmbH ×3 presentaciones | 20 de junio de 2017 | · | Presentación inicial | Inversión pasiva | SEC |
| Technion Research and Development Foundation Ltd. ×2 presentaciones | 9 de enero de 2017 | · | Presentación inicial | Inversión pasiva | SEC |
| Alpha Capital Anstalt (2) | 8 de diciembre de 2016 | · | Presentación inicial | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Informantes de la empresa 36 insiders · 16 directivos · 20 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| Harel Gadot | Chairman, President and CEO | 18 de febrero de 2026 A | 136 847 | 0 | 0 | $0 |
| Ian J Massey | Chief Executive Officer | 15 de marzo de 2016 A | 2 378 460 | 0 | 0 | $0 |
| Martin M Mcglynn | President & CEO | 8 de enero de 2016 F | 2 230 297 | 0 | 0 | $0 |
| Rachel Vaknin | Chief Financial Officer | 18 de febrero de 2026 A | · | 0 | 0 | $0 |
| David Ben Naim | Chief Financial Officer | 28 de diciembre de 2017 A | · | 0 | 0 | $0 |
| Gregory T Schiffman | Chief Financial Officer | 14 de marzo de 2016 P | 1 599 717 | 0 | 0 | $0 |
| Rodney Kb Young | CFO | 1 de junio de 2013 F | 36 745 | 0 | 0 | $0 |
| Judi R Lum | CFO | 30 de septiembre de 2005 J | 1 421 | 0 | 0 | $0 |
| Yehezkel Himelfarb | COO and General Manager | 15 de octubre de 2017 A | · | 0 | 0 | $0 |
| Juan Diaz-Cartelle | Chief Medical Officer | 18 de febrero de 2026 A | · | 0 | 0 | $0 |
| Simon Sharon | General Manager, CTO | 18 de febrero de 2026 A | · | 0 | 0 | $0 |
| Eyal Morag | Chief Medical Officer | 1 de agosto de 2023 A | · | 0 | 0 | $0 |
| Kenneth Blair Stratton | General Counsel | 17 de junio de 2016 F | 42 273 | 0 | 0 | $0 |
| Ann Tsukamoto | EVP, Research and Development | 27 de enero de 2015 F | 706 511 | 0 | 0 | $0 |
| Stewart Craig | SVP, Development & Operations | 27 de enero de 2014 F | 405 981 | 0 | 0 | $0 |
| Eliseo Oreste Salinas | EVP and Head of R&D | 6 de junio de 2013 A | 390 000 | 0 | 0 | $0 |
| David James Wilson | Consejero | 1 de abril de 2026 A | · | 0 | 0 | $0 |
| Tal Baruch Wenderow | Consejero | 1 de abril de 2026 A | · | 0 | 0 | $0 |
| Aileen Ptucha Stockburger | Consejero | 1 de abril de 2026 A | · | 0 | 0 | $0 |
| Prattipati Laxminarain | Consejero | 1 de abril de 2026 A | · | 0 | 0 | $0 |
| Martin J. Madden | Consejero | 1 de abril de 2026 A | · | 0 | 0 | $0 |
| Scott R Burell | Consejero | 1 de abril de 2026 A | · | 0 | 0 | $0 |
| Yoseph Bornstein | Consejero | 2 de noviembre de 2023 A | 246 909 | 0 | 0 | $0 |
| Yoav Zvi Waizer | Consejero | 23 de octubre de 2019 A | 0 | 0 | 0 | $0 |
| Moshe Shoham | Consejero | 9 de octubre de 2017 S | 1 558 390 | 0 | 0 | $0 |
| Irving Weissman | Consejero | 1 de abril de 2016 A | 558 288 | 0 | 0 | $0 |
| Alan O Trounson | Consejero | 1 de enero de 2016 A | 354 595 | 0 | 0 | $0 |
| John J Schwartz | Consejero | 1 de enero de 2016 A | 334 673 | 0 | 0 | $0 |
| Scott R Greer | Consejero | 1 de enero de 2016 A | 290 183 | 0 | 0 | $0 |
| Eric Bjerkholt | Consejero | 1 de enero de 2016 A | 273 759 | 0 | 0 | $0 |
| Ricardo B Levy | Consejero | 1 de enero de 2016 A | 260 033 | 0 | 0 | $0 |
| Roger M Perlmutter | Consejero | 14 de diciembre de 2012 A | 13 000 | 0 | 0 | $0 |
| Desmond H Oconnell JR | Consejero | 7 de marzo de 2007 P | 10 500 | 0 | 0 | $0 |
| Leon Lewkowicz | Propietario del 10% | 16 de junio de 2017 S | 3 078 214 | 0 | 0 | $0 |
| Alpha Capital Anstalt | Propietario del 10% | 28 de noviembre de 2016 J | 1 776 457 | 0 | 0 | $0 |
| George Koshy | · | 24 de mayo de 2016 F | 27 308 | 0 | 0 | $0 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Propiedad de ETFs Mantenido por 4 ETFs
El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.
| Fondo | Ponderación | Unidades | A fecha de | Fuente |
|---|---|---|---|---|
| QQQS · Invesco Exchange-Traded Fund Trust … | 0,42% | 80 526 SH | 2 de octubre de 2026 | Diario |
| IWC · iShares Trust | 0,02% | 229 405 SH | 11 de septiembre de 2026 | Diario |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 739 816 SH | 19 de agosto de 2026 | Diario |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 2 109 889 SH | 19 de agosto de 2026 | Diario |
MBOT Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
calificación · 9 analistas
COMPRA
Objetivo mediano
$4.00
+244,8%
2 22,2%
Compra fuerte
6 66,7%
Compra
1 11,1%
Mantener
0 0,0%
Venta
0 0,0%
Venta fuerte
Precio objetivo a 12 meses
3 analistas · 2026-10-03Objetivo medio $6.33 +446,0%
← Por Debajo de Todos los Objetivos
Precio Actual $1.16
Mín$3.00
Media$6.33
Máx$12.00
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
Base del ejercicio fiscal, precios al cierre del último ejercicio fiscal de cada empresa.
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| MBOT | $134M | -6.9 | · | · | -24.4% | · |
| LNSR | · | -4.1 | 9.2% | · | · | · |
| LUNG | $92M | -1.7 | 8.0% | -59.7% | -87.7% | 74.2% |
| OM | $67M | -0.7 | 5.1% | -68.3% | -58.0% | 39.1% |
| VANI | $94M | -2.9 | · | · | -257.8% | · |
| STEX | $151M | -0.3 | 122.2% | 29068.8% | -703.0% | · |
| GUTS | $337M | -1.2 | -22.5% | · | 3220.3% | · |
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
Seleccione las métricas que le importan: haga clic en el + junto a cualquier fila en Fundamentales completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Fuente: SEC 10-Q presentada el Ago 11, 2026